CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression.

doi:10.1007/s13277-013-0783-2

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Aug 2013

Wang Bao-Sheng, Liu Zhen, Xu Wei-Xue, Sun Shao-Long

Abstract excerpt

CYP3A5 is a cytochrome P450 superfamily member which is involved in the metabolism of drugs, steroid hormones, and other xenobiotics. Emerging evidences suggest that CYP3A5*3 (rs776746 A>G) polymorphism may play a role in the etiology of carcinogenesis and affect an individual's susceptibility to cancer in humans, but individually published studies showed inconclusive results. This meta-analysis aimed to derive a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Black People

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to Cytochrome P-450 CYP3A

Share to Leukemia

Share to Liver Neoplasms

Share to Prostatic Neoplasms

Share to Risk

Share to White People

Source

Open in PubMed

Identifiers

PMID: 23584898
DOI: 10.1007/s13277-013-0783-2

Genes

CYP3A5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression.PMID 23584898Read ↗

CYP3A4*1B polymorphism and cancer risk: a HuGE review and meta-analysis.Semantic proximity Read ↗

CYP3A4*1B Polymorphism and Cancer Risk: A Meta-Analysis Based on 55 Case-control Studies.Semantic proximity Read ↗

Association of CYP3A5*3 polymorphisms and prostate cancer risk: A meta-analysis.Semantic proximity Read ↗

Association between the CYP3A4 and CYP3A5 polymorphisms and cancer risk: a meta-analysis and meta-regression.Semantic proximity Read ↗

Analysis of CYP3A5*3 and CYP3A5*6 gene polymorphisms in Indian chronic myeloid leukemia patients.Semantic proximity Read ↗

CYP3A5 ∗ 3 genetic polymorphism is associated with childhood acute lymphoblastic leukemia risk: A meta-analysis.Semantic proximity Read ↗

Genetic variants of CYP2D6 gene and cancer risk: a HuGE systematic review and meta-analysis.Semantic proximity Read ↗

CYP 3A5*3 Gene Polymorphism Among Sudanese Patients With Chronic Myeloid Leukemia Semantic proximity Read ↗

Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients.Semantic proximity Read ↗

Cytochrome P450 gene polymorphism and cancer.Semantic proximity Read ↗

Title: Impact of CYP3A5*3 genetic polymorphism on breast cancer risk: Evidence from Bangladesh.Semantic proximity Read ↗

Single-nucleotide polymorphism in CYP1A1, CYP1B1, CYP2B6, CYP2C8, and CYP2C9 genes and their association with gastrointestinal cancer: A hospital-based case-control study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.